Colrain Capital LLC Vertex Pharmaceuticals Inc Transaction History
Colrain Capital LLC
- $99.1 Million
- Q4 2024
A detailed history of Colrain Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Colrain Capital LLC holds 1,696 shares of VRTX stock, worth $768,627. This represents 0.69% of its overall portfolio holdings.
Number of Shares
1,696
Previous 10,000
83.04%
Holding current value
$768,627
Previous $2.9 Million
76.44%
% of portfolio
0.69%
Previous 4.83%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
223MCall Options Held
1.64MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.5 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.66 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.36 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.08 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...